Cargando…
An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics
BACKGROUND: The systematic review of economic evaluations plays a critical role in making well-informed decisions about competing healthcare interventions. The quality of these systematic reviews varies due to the lack of internationally recognized methodological evaluation standards. METHODS: Nine...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870091/ https://www.ncbi.nlm.nih.gov/pubmed/33556056 http://dx.doi.org/10.1371/journal.pone.0246080 |
_version_ | 1783648743759806464 |
---|---|
author | Min, Chen Xue, Mi Haotian, Fei Jialian, Li Lingli, Zhang |
author_facet | Min, Chen Xue, Mi Haotian, Fei Jialian, Li Lingli, Zhang |
author_sort | Min, Chen |
collection | PubMed |
description | BACKGROUND: The systematic review of economic evaluations plays a critical role in making well-informed decisions about competing healthcare interventions. The quality of these systematic reviews varies due to the lack of internationally recognized methodological evaluation standards. METHODS: Nine English and Chinese databases including the Cochrane Library, PubMed, EMbase (Ovid), NHS economic evaluation database (NHSEED) (Ovid), Health Technology Assessment (HTA) database, Chinese National Knowledge Infrastructure (CNKI), WangFang, VIP Chinese Science & Technology Periodicals (VIP) and Chinese Biomedical Literature Database (CBM) were searched. Two reviewers independently screened studies and extracted data. The methodological quality of the literature was measured with modified AMSTAR. Data were narrative synthesized. RESULTS: 165 systematic reviews were included. The overall methodological quality of the literature was moderate according to the AMSTAR scale. In these articles, thirteen quality assessment tools and 32 author self-defined criteria were used. The three most widely used tools were the Drummond checklist (19.4%), the BMJ checklist (15.8%), the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (12.7%). Others included the Quality of Health Economic Studies (QHES), the Consensus on Health Economic Criteria (CHEC), the checklist of Center for Reviews and Dissemination (CRD), the Philips checklist, the World Health Organization (WHO) checklist, the checklist of Critical Appraisal Skills Program (CASP), the Pediatric Quality Appraisal Questionnaire (PQAQ), the Joanna Briggs Institute (JBI) checklist, Spanish and Chinese guidelines. The quantitative scales used in these literature were the QHES and PQAQ. CONCLUSIONS: Evidence showed that pharmacoeconomic systematic reviews’ methodology remained to be improved, and the quality assessment criteria were gradually unified. Multiple scales can be used in combination to evaluate the quality of economic research in different settings and types. |
format | Online Article Text |
id | pubmed-7870091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-78700912021-02-11 An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics Min, Chen Xue, Mi Haotian, Fei Jialian, Li Lingli, Zhang PLoS One Research Article BACKGROUND: The systematic review of economic evaluations plays a critical role in making well-informed decisions about competing healthcare interventions. The quality of these systematic reviews varies due to the lack of internationally recognized methodological evaluation standards. METHODS: Nine English and Chinese databases including the Cochrane Library, PubMed, EMbase (Ovid), NHS economic evaluation database (NHSEED) (Ovid), Health Technology Assessment (HTA) database, Chinese National Knowledge Infrastructure (CNKI), WangFang, VIP Chinese Science & Technology Periodicals (VIP) and Chinese Biomedical Literature Database (CBM) were searched. Two reviewers independently screened studies and extracted data. The methodological quality of the literature was measured with modified AMSTAR. Data were narrative synthesized. RESULTS: 165 systematic reviews were included. The overall methodological quality of the literature was moderate according to the AMSTAR scale. In these articles, thirteen quality assessment tools and 32 author self-defined criteria were used. The three most widely used tools were the Drummond checklist (19.4%), the BMJ checklist (15.8%), the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (12.7%). Others included the Quality of Health Economic Studies (QHES), the Consensus on Health Economic Criteria (CHEC), the checklist of Center for Reviews and Dissemination (CRD), the Philips checklist, the World Health Organization (WHO) checklist, the checklist of Critical Appraisal Skills Program (CASP), the Pediatric Quality Appraisal Questionnaire (PQAQ), the Joanna Briggs Institute (JBI) checklist, Spanish and Chinese guidelines. The quantitative scales used in these literature were the QHES and PQAQ. CONCLUSIONS: Evidence showed that pharmacoeconomic systematic reviews’ methodology remained to be improved, and the quality assessment criteria were gradually unified. Multiple scales can be used in combination to evaluate the quality of economic research in different settings and types. Public Library of Science 2021-02-08 /pmc/articles/PMC7870091/ /pubmed/33556056 http://dx.doi.org/10.1371/journal.pone.0246080 Text en © 2021 Min et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Min, Chen Xue, Mi Haotian, Fei Jialian, Li Lingli, Zhang An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics |
title | An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics |
title_full | An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics |
title_fullStr | An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics |
title_full_unstemmed | An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics |
title_short | An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics |
title_sort | overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870091/ https://www.ncbi.nlm.nih.gov/pubmed/33556056 http://dx.doi.org/10.1371/journal.pone.0246080 |
work_keys_str_mv | AT minchen anoverviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics AT xuemi anoverviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics AT haotianfei anoverviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics AT jialianli anoverviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics AT linglizhang anoverviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics AT minchen overviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics AT xuemi overviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics AT haotianfei overviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics AT jialianli overviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics AT linglizhang overviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics |